136 related articles for article (PubMed ID: 22023065)
1. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Choudhury A; Cowan R
BJU Int; 2011 Nov; 108(9):E313. PubMed ID: 22023065
[No Abstract] [Full Text] [Related]
2. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
[TBL] [Abstract][Full Text] [Related]
3. Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
Zietman AL; Shipley WU; Kaufman DS; Esrig D; Lytton B
Contemp Urol; 1995 Jul; 7(7):23-4, 29, 32, passim. PubMed ID: 10150577
[No Abstract] [Full Text] [Related]
4. Radical cystectomy versus alternative treatments for muscle-confined bladder cancer.
Tekin A; Aki FT; Ozen H
Int Urol Nephrol; 2001; 33(2):357-62. PubMed ID: 12092656
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
Simon SD; Srougi M
Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
[No Abstract] [Full Text] [Related]
6. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
Freiha F; Reese J; Torti FM
J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M
Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021
[TBL] [Abstract][Full Text] [Related]
8. Selective bladder preservation by combination treatment of invasive bladder cancer.
Kaufman DS; Shipley WU; Griffin PP; Heney NM; Althausen AF; Efird JT
N Engl J Med; 1993 Nov; 329(19):1377-82. PubMed ID: 8413433
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
[No Abstract] [Full Text] [Related]
11. Neoadjuvant chemotherapy in deeply invasive bladder cancer: the Italian experience. The Lombard Urologists.
Semin Urol; 1990 Aug; 8(3):205-9. PubMed ID: 2204982
[No Abstract] [Full Text] [Related]
12. Invasive bladder cancer--where do we go from here?
Waters WB
J Urol; 1996 Jun; 155(6):1910-1. PubMed ID: 8618285
[No Abstract] [Full Text] [Related]
13. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
[TBL] [Abstract][Full Text] [Related]
14. Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.
Mitin T; Shipley WU; Efstathiou JA; Heney NM; Kaufman DS; Lee RJ; Zietman AL
Curr Urol Rep; 2013 Apr; 14(2):109-15. PubMed ID: 23341373
[TBL] [Abstract][Full Text] [Related]
15. Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080).
Crawford ED; Natale RB; Burton H
Prog Clin Biol Res; 1990; 353():111-3. PubMed ID: 2217407
[No Abstract] [Full Text] [Related]
16. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI; Stadler WM; Bajorin DF
BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
[TBL] [Abstract][Full Text] [Related]
17. The integration of chemotherapy and surgery for bladder cancer.
Galsky MD; Herr HW; Bajorin DE
J Natl Compr Canc Netw; 2005 Jan; 3(1):45-51. PubMed ID: 19813322
[TBL] [Abstract][Full Text] [Related]
18. Bladder cancer: clinical practice.
Rabinowits G; Laber DA
J Ky Med Assoc; 2009 Apr; 107(4):129-33. PubMed ID: 19419018
[No Abstract] [Full Text] [Related]
19. Locally advanced bladder cancer. Radiation therapy and chemotherapy.
Gospodarowicz MK
Eur Urol; 1998; 33 Suppl 4():27-31. PubMed ID: 9615207
[No Abstract] [Full Text] [Related]
20. Advanced bladder cancer: options of therapy.
Pontes JE
Cancer Chemother Pharmacol; 1994; 35 Suppl():S93-6. PubMed ID: 7994796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
